These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21795655)

  • 21. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.
    Lynch BA; Lambeng N; Nocka K; Kensel-Hammes P; Bajjalieh SM; Matagne A; Fuks B
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9861-6. PubMed ID: 15210974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An open-label, prospective study of levetiracetam in children and adolescents with Tourette syndrome.
    Fernández-Jaén A; Fernández-Mayoralas DM; Muñoz-Jareño N; Calleja-Pérez B
    Eur J Paediatr Neurol; 2009 Nov; 13(6):541-5. PubMed ID: 19211282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
    Perry S; Holt P; Benatar M
    J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy.
    Lancelin F; Franchon E; Kraoul L; Garciau I; Brovedani S; Tabaouti K; Landré E; Chassoux F; Paubel P; Piketty ML
    Ther Drug Monit; 2007 Oct; 29(5):576-83. PubMed ID: 17898647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of levetiracetam on testosterone levels in male patients.
    Harden CL; Nikolov BG; Kandula P; Labar DR; Pannullo S
    Epilepsia; 2010 Nov; 51(11):2348-51. PubMed ID: 21175608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein.
    Wood MD; Gillard M
    Epilepsia; 2017 Feb; 58(2):255-262. PubMed ID: 28012162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome.
    Hedderick EF; Morris CM; Singer HS
    Pediatr Neurol; 2009 Jun; 40(6):420-5. PubMed ID: 19433274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levetiracetam in absence epilepsy.
    Verrotti A; Cerminara C; Domizio S; Mohn A; Franzoni E; Coppola G; Zamponi N; Parisi P; Iannetti P; Curatolo P
    Dev Med Child Neurol; 2008 Nov; 50(11):850-3. PubMed ID: 18808424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S; Cao J; Xiao N; Cai F
    J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levetiracetam efficacy in epileptic syndromes with continuous spikes and waves during slow sleep: experience in 12 cases.
    Aeby A; Poznanski N; Verheulpen D; Wetzburger C; Van Bogaert P
    Epilepsia; 2005 Dec; 46(12):1937-42. PubMed ID: 16393159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.
    Milligan TA; Hurwitz S; Bromfield EB
    Neurology; 2008 Aug; 71(9):665-9. PubMed ID: 18725591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levetiracetam: a long-term follow-up study of efficacy and safety.
    Bauer J; Ben-Menachem E; Krämer G; Fryze W; Da Silva S; Kasteleijn-Nolst Trenité DG
    Acta Neurol Scand; 2006 Sep; 114(3):169-76. PubMed ID: 16911344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy.
    Specchio LM; Gambardella A; Giallonardo AT; Michelucci R; Specchio N; Boero G; La Neve A
    Epilepsy Res; 2006 Sep; 71(1):32-9. PubMed ID: 16814521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents.
    Verrotti A; Cerminara C; Coppola G; Franzoni E; Parisi P; Iannetti P; Aloisi P; Tozzi E; Cusmai R; Vigevano F; Chiarelli F; Curatolo P
    Dev Med Child Neurol; 2008 Jan; 50(1):29-32. PubMed ID: 18173626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age.
    Krief P; Li Kan ; Maytal J
    J Child Neurol; 2008 May; 23(5):582-4. PubMed ID: 18448575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A combination of levetiracetam and tiapride for outpatient alcohol detoxification: a case series.
    Müller CA; Schäfer M; Banas R; Heimann HM; Volkmar K; Förg A; Heinz A; Hein J
    J Addict Med; 2011 Jun; 5(2):153-6. PubMed ID: 21769061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M
    Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy.
    Piazzini A; Chifari R; Canevini MP; Turner K; Fontana SP; Canger R
    Epilepsy Res; 2006 Mar; 68(3):181-8. PubMed ID: 16332430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.